Could big pharma actually lose this fight over drug prices? It's Biden's call.

3 June 2021 - More than 20 years ago, when I was the press secretary for then-Congressman Bernie Sanders, I rode ...

Read more →

Terminal cancer patients denied new treatments due to slow TGA approval

31 March 2021 - Desperate cancer patients are begging Australia’s drugs regulator to save lives by speeding up approvals and cutting ...

Read more →

FDA statement on following the authorised dosing schedules for COVID-19 vaccines

4 January 2021 - Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease ...

Read more →

Is it time for the FDA to be independent?

3 November 2020 - Public health experts and lay observers alike have expressed concerns that, under political pressure, the FDA ...

Read more →

US may need to look to Germany to reform drug pricing

19 August 2020 - US administrative and legislative efforts are moving the United States and Germany more into alignment on drug ...

Read more →

Congress should set fair rules that force drug corporations to negotiate prices

14 October 2019 - As a pastor, I am deeply invested in the health and well being of my community. ...

Read more →

New rules will keep the best medications from desperate Canadians

12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...

Read more →

Trump directs Azar to work on Florida drug import plan

6 May 2019 - President Donald Trump on Monday directed Health and Human Services Secretary Alex Azar to work with ...

Read more →

'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA chief says

26 February 2019 - "The sick people are helping to subsidise the healthy people. That's not how insurance is supposed to ...

Read more →

Sanders unveils aggressive new bill targeting drug prices

20 November 2018 - Sen. Bernie Sanders and Rep. Ro Khanna on Tuesday unveiled a bill aimed at aggressively lowering ...

Read more →

Drug company ‘shenanigans’ to block generics come under federal scrutiny

14 April 2018 - Trump administration officials, seeking ways to lower drug costs, are targeting pharmaceutical companies that refuse to ...

Read more →

Product withdrawn after overseas reports of inflammatory brain disorders

15 March 2018 - Consumers and health professionals are advised that Biogen Australia, in consultation with the TGA, will withdraw ...

Read more →

Advance notice of consultation about changes to the Pharmaceutical Schedule Rules

1 February 2018 - PHARMAC is working to make the Pharmaceutical Schedule Rules easier to find, use and apply.  ...

Read more →

U.S. Government should negotiate drug prices, adviser group says

30 November 2017 - National Academies releases report with recommendations. ...

Read more →

EMA to relocate to Amsterdam, the Netherlands

20 November 2017 - Agency to begin working immediately with Dutch government to ensure successful move by end of March ...

Read more →